Report Detail

Financial Services Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report

  • RnM1029498
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 36 pages
  • |
  • MarketLine
  • |
  • Financial Services

Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report

Table of Contents

    Company Snapshot

      Table of Contents

        Enzymotec Ltd: Company Overview

          Enzymotec Ltd: Overview and Key Facts

            Enzymotec Ltd: Overview

              Enzymotec Ltd: Key Facts

                Enzymotec Ltd: Key Employees

                  Enzymotec Ltd: Key Employee Biographies

                    Enzymotec Ltd: Major Products and Services

                      Enzymotec Ltd: Company History

                        Enzymotec Ltd: Management Statement

                          Enzymotec Ltd: Locations and Subsidiaries

                            Enzymotec Ltd: Key Competitors

                              Enzymotec Ltd: Company Analysis

                                Enzymotec Ltd: Business Description

                                  Enzymotec Ltd: SWOT Analysis

                                    Enzymotec Ltd: SWOT Overview

                                      Enzymotec Ltd: Strengths

                                        Enzymotec Ltd: Weaknesses

                                          Enzymotec Ltd: Opportunities

                                            Enzymotec Ltd: Threats

                                              Enzymotec Ltd: Corporate Financial Deals Activity

                                                Enzymotec Ltd: Financial Deals Overview

                                                  Enzymotec Ltd: Top Deals 2015 - 2019YTD*

                                                    Enzymotec Ltd: Advisors

                                                      Enzymotec Ltd: Top Legal Advisors

                                                        Enzymotec Ltd: Mergers and Acquisitions

                                                          Enzymotec Ltd: Private Equity and Ownership

                                                            Enzymotec Ltd: Recent Developments

                                                              Enzymotec Ltd: News and Events Summary

                                                                Enzymotec Ltd: Business Expansion

                                                                  Enzymotec Ltd: Contracts

                                                                    Enzymotec Ltd: Corporate Governance

                                                                      Enzymotec Ltd: Financial Performance

                                                                        Enzymotec Ltd: Market Developments

                                                                          Appendix

                                                                            Contact Us

                                                                              Methodology

                                                                                About MarketLine

                                                                                Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report

                                                                                Summary

                                                                                Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

                                                                                Key Highlights

                                                                                Enzymotec Ltd (Enzymotec), a subsidiary of Frutarom Industries Ltd., produces, and markets of nutritional ingredients and medical foods for the entire human life-cycle such as from infancy to old age. The company develops clinically-validated products including bio-functional, lipid-based compounds compounds which meet a wide range of consumer demands on optimal development, supplementation for nutritional deficiencies and needs, and the management of medical disorders and diseases. Its major products include Infat, EnzyPS Solutions, Vayacog, Vayarin, Vayarol, NoctoPlex, LuciPlex, NoctoPlex for kids, and Addivance for kids. The company market products under Vayacog,INFAT,Vayarin, SHARP PS, SHARP PS GREEN,NOCTOPLEX, NOCTOPLEX for Kids, and LUCIPLEX brand names. The company has business presence in India, the US, China, and Sweden. Enzymotec is headquartered in Migdal HaEmek, Israel.

                                                                                Scope

                                                                                - Detailed information on Enzymotec Ltd required for business and competitor intelligence needs
                                                                                - A study of the major internal and external factors affecting Enzymotec Ltd in the form of a SWOT analysis
                                                                                - An in-depth view of the business model of Enzymotec Ltd including a breakdown and examination of key business segments
                                                                                - Intelligence on Enzymotec Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
                                                                                - News about Enzymotec Ltd, such as business expansion, restructuring, and contract wins
                                                                                - Large number of easy-to-grasp charts and graphs that present important data and key trends

                                                                                Reasons to buy

                                                                                - Gain understanding of Enzymotec Ltd and the factors that influence its strategies.
                                                                                - Track strategic initiatives of the company and latest corporate news and actions.
                                                                                - Assess Enzymotec Ltd as a prospective partner, vendor or supplier.
                                                                                - Support sales activities by understanding your customers' businesses better.
                                                                                - Stay up to date on Enzymotec Ltd's business structure, strategy and prospects.



                                                                                REPORT YOU MIGHT BE INTERESTED

                                                                                Purchase this Report

                                                                                $175.00
                                                                                $350.00
                                                                                $525.00
                                                                                138.44
                                                                                276.87
                                                                                415.31
                                                                                155.52
                                                                                311.03
                                                                                466.55
                                                                                18,965.28
                                                                                37,930.55
                                                                                56,895.83
                                                                                12,197.62
                                                                                24,395.25
                                                                                36,592.87
                                                                                Credit card Logo

                                                                                Related Reports


                                                                                Reason to Buy

                                                                                Request for Sample of this report